Description
VPDiagnostics currently offers MRI-PlaqueView, a FDA cleared plaque characterization product for quantitative analysis of atherosclerotic carotid arteries. Atherosclerosis analysis can assist clinicians in planning for the optimal preventive treatment based on scientific evidences. It also enables timely and quantitative monitor of atherosclerosis progression in treatment research and in clinical management.
Team Members
Hui Hu
President
William Kerwin
VP of Research and Development, Research Associate Professor in Radiology and Associate Director of Vascular Imaging Laboratory, University of Washington
Mike Hartmann
VP of Business and Product Development
DongXiang Zu
VP of Engineering
